Web-based analytics have demonstrated their value in predicting the spread of infectious disease, and a new study from Mayo Clinic indicates the value of analyzing Google web searches for keywords related to COVID-19.
Non-pharmaceutical interventions such as voluntary shelter-in-place, quarantines, and other steps taken to control the SARS-CoV-2 virus can reduce the peak number of infections, daily infection rates, cumulative infections, and overall deaths, a new study published in the journal PLOS ONE has found.
University of Minnesota Medical School researchers found that taking hydroxychloroquine once or twice weekly did not prevent the development of COVID-19 in health care workers better than the placebo.
1. Down Syndrome associated with a 10-fold increased risk for COVID-19-related death ; 2. Ensuring Safe Access to Mifepristone During the Pandemic and Beyond
Despite guidelines plastered on the walls and floors of grocery and retail stores encouraging customers to maintain six-feet of physical distance during the pandemic, many do not. A new study by researchers at the Conrad N. Hilton College of Hotel and Restaurant Management identifies two key messaging components that could improve the persuasiveness of those appeals and trigger compliance.
Dirk Dittmer, PhD, professor of microbiology and immunology at the UNC School of Medicine, is tracking the virus that causes COVID-19 by sequencing the genome of virus samples collected from diagnostic testing. Using next generation sequencing on SARS-CoV-2 will help accurately diagnose the novel coronavirus, identify mutations and track its history.
Two studies examining the impact of COVID-19 on neonatal intensive care units (NICUs) found the prevalence of COVID-19 in NICU infants is low, yet many hospitals at the start of the pandemic put in place strict parental visitation policies and scaled back NICU services such as lactation support and therapy.
People have different susceptibilities to SARS-CoV-2, the virus behind the COVID-19 pandemic, and develop varying degrees of fever, fatigue, and breathing problems -- common symptoms of the illness. What might explain this variation? Scientists at the University of California, Riverside, and University of Southern California may have an answer to this mystery.
Computer modeling of the COVID-19 virus on supercomputers showed that the spike protein visits an intermediate state before it can dock to the receptor protein on the host cell membrane. This intermediate state can be useful for drug targeting to prevent the spike protein to initiate viral infection. The initial findings, which showed the existence of an intermediate semi-open state of the spike protein, was published in the Journal of Chemical Physics.
Using a new mathematical approach to screen large groups for COVID-19 could be around 20 times cheaper than individual testing, a study suggests.